A 2-PAM@bio-MOF-1 composite was prepared by cationic
exchange of
counter
N
,
N
-dimethylammonium cations
in the pores of the anionic, biocompatible metal–organic framework
(bio-MOF-1) with pralidoxime chloride (2-PAM-Cl) by impregnation.
In vitro drug release measurements revealed that the release rate
of 2-PAM from 2-PAM@bio-MOF-1 in simulated body fluid (SBF) was more
than four-fold higher than that in deionized water, indicating that
the presence of endogenous cations in SBF triggered the release of
2-PAM through cation exchange. The release of 2-PAM was rapid within
the first 10 h but was much slower over the period of 10–50
h. At room temperature, the maximum release rate of 2-PAM was 88.5%
(15 mg of 2-PAM@bio-MOF-1 in 1 mL of SBF), indicating that the drug
was efficiently released from the composite MOF in SBF. In simulated
gastric fluid, 64.3% of 2-PAM was released from bio-MOF-1 into the
simulated gastric fluid after 50h. This suggested that 2-PAM@bio-MOF-1
might be effective for enabling the slow release of 2-PAM in the human
body. Indeed, the maximum reactivation rate of acetylcholinesterase
in sarin-poisoned mice reached 82.5%. In addition, 2-PAM@bio-MOF-1
demonstrated the ability to adsorb and remove sulfur mustard (HD)
in solution and from the skin of guinea pigs.